Literature DB >> 27078188

Long-Term Clinical Outcomes of Myopic Patients Having Thin Residual Corneal Thickness after Excimer Laser Surface Ablation.

Sücattin İlker Kocamış1, Hasan Basri Çakmak2, Sıdıka Gerçeker3, Nurullah Çağıl4.   

Abstract

PURPOSE: To investigate and compare the long-term safety, efficacy, and accuracy of PRK (photorefractive keratectomy) and LASEK (laser epithelial keratomileusis) in myopic corneas having residual corneal thickness less than 400 micron meters (µm).
METHODS: The medical reports of the patients who had undergone excimer laser surface ablation between 2007-2011 and had a residual corneal thickness less than 400 µm were retrospectively reviewed.
RESULTS: Forty-two eyes of 42 patients with a mean age of 28.79±7.76 years were enrolled into the study. Twenty-two PRK and 20 LASEK procedures were performed. The mean follow-up time was 45.00±11.80 months. At the end of follow-up, no ectasia was detected. Nineteen percent of eyes had trace haze. No eyes lost any lines in corrected distance visual acuity. Eighty-one percent of the patients had an uncorrected distance visual acuity better than 20/40. The regression rate was 16.7%. Sixty-two percent of eyes were within ±1.00 D. The safety and efficacy indexes were 1.19±0.42 and 1.00±0.40, respectively. There was not any difference between LASEK and PRK regarding achieved spherical equivalent refraction, haze ratio, visual acuity, safety, efficacy, and regression.
CONCLUSIONS: Both PRK and LASEK are safe and effective in myopic corneas having thin residual thickness.

Entities:  

Keywords:  Ectasia; laser epithelial keratomileusis; mitomycin-C; photorefractive keratectomy; residual thin cornea

Mesh:

Year:  2016        PMID: 27078188     DOI: 10.3109/08820538.2015.1120755

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  1 in total

1.  Refractive and visual outcomes of small incision lenticule extraction (SMILE) in eyes with thin corneas.

Authors:  Asli Kirmaci Kabakci; Burcin Kepez Yildiz; Yusuf Yildirim; Alper Agca; Fevziye Ondes Yilmaz; Gokhan Demir; Beril Tulu Aygun; Ahmet Demirok
Journal:  Eye (Lond)       Date:  2020-11-02       Impact factor: 4.456

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.